English  |  正體中文  |  简体中文  |  2826208  
???header.visitor??? :  31893333    ???header.onlineuser??? :  1753
???header.sponsordeclaration???
 		 
???search.scope??? ???search.advance???
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???
???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
Repositories
Author
Title
Date
???ui.leftmenu.statisticschart???
???ui.leftmenu.realtimefacts???
???ui.leftmenu.trend???

???index.news???
2019臺灣學術機構典藏
研討會
機構典藏系統RC7版本已
發佈

???ui.leftmenu.copyrighttitle???
???ui.leftmenu.copyrightpublisher???
???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
機構典藏計畫網站
ROAR
OpenDOAR
SHERPA
OAIster
JAIRO
Ira
DSPACE
RWWR
臺大學術典藏NTU Scholars
???tair.name??? >  ???browser.page.title.author???

"morel c"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-4 of 4  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-05-13T08:04:17Z Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria Chen G.-J.; Pan S.-C.; Foo J.; Morel C.; Chen W.-T.; JANN-TAY WANG
臺大學術典藏 2019 Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria Chen W.-T.; Wang J.-T.; Morel C.; Foo J.; SUNG-CHING PAN; Chen G.-J.; Chen G.-J.;Sung-Ching Pan;Foo J.;Morel C.;Chen W.-T.;Wang J.-T.
臺大學術典藏 2019 Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria Chen W.-T.; Wang J.-T.; Morel C.; Foo J.; SUNG-CHING PAN; Chen G.-J.; Chen G.-J.;Sung-Ching Pan;Foo J.;Morel C.;Chen W.-T.;Wang J.-T.
臺大學術典藏 2019 Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria Chen G.-J.; Pan S.-C.; Foo J.; Morel C.; Chen W.-T.; JANN-TAY WANG

Showing items 1-4 of 4  (1 Page(s) Totally)
1 
View [10|25|50] records per page

DSpace Software Copyright © 2002-2004  MIT   &  Hewlett-Packard   /   Enhanced by   NTU Library IR team